Gefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility study

BACKGROUND: This pilot, open-label study examined the safety and tolerability (primary objective) and efficacy (secondary objective) of gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in combination with celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yamaguchi, Nise H., Mayer, Ingrid A., Malzyner, Artur, de Andrade, Carlos JC, Murad, Andre M., del Giglio, Auro, Alves, Venancio
Formato: Artigo
Idioma:Inglês
Publicado em: Pioneer Bioscience Publishing Company 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904021/
https://ncbi.nlm.nih.gov/pubmed/24490043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2013.056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados